Business Strategy

How managed care organizations manage opioid utilization and some of the limitations to those management strategies was a hot topic at the AMCP Annual Meeting.

A study from Walgreens provides a benchmark of basal insulin treatment persistence across different payers in the United States.

Here are four of the top benefits of incorporating behavioral health management into care management plans for members with chronic conditions.

Here are five key security risk assessment elements to identify and remediate.

Our policy analyst weighs in on a new drug industry PR campaign that attempts to shift the blame for high drug costs.

Here are four ways that health plans can improve their internal processes for collecting provider data.

Here are five critical regulations that executives can begin to prepare for today.

Researchers create a set of recommendations for transparency at the agency in five principal areas.

Healthcare leaders are concerned about developing reliable strategies for the future. Is effective strategic and financial planning even possible with so many variables up in the air?

With ACA repeal and replace on the horizon, digital healthcare solutions will surely be affected.

What should managed care executives know about the GOP ACA replacement plan? Find out.

A West survey finds that an overwhelming number of chronic care patients say they need help managing their disease.

Include medication-assisted treatment high on the list of clinical tools used to treat opioid addiction.

ACA repeal or replacement must focus on how to preserve mental health services and pharmacy access.

Creating a system where health outcomes are paramount is key. Here’s what stakeholders need to do.

Industry leaders share their go-to strategies.

Seven ways health execs can prepare for the future.

While Trump has touted Obamacare as a “disaster,” some healthcare experts say the change could negatively impact hospitals in a variety of ways.

Health plans of the future will focus on consumers: designing products, care and services to support improved health.

Integrating businesses is complex, but experts shed light on other options including partnerships and shared services.

Biomarker testing for harmful genetic mutations provides the opportunity to identify at-risk individuals who might benefit from risk modification strategies and/or enhanced disease screening.

New treatment indications are under investigation for the use of cannabinoid-based drugs. Are you ready?

Stephen Rioseco, of Horizon BCBSNJ, tells Managed Healthcare Executive how his health plan fully capitalizes on the power of social media for customer service.

Paramedics can do much more than transport patients to the ED or inpatient care. Payers and providers are increasingly using EMS services to reach out to patients in their homes to improve outcomes and reduce costs.

Genetic testing holds great promise, but there are some critical drawbacks to consider.